Denmark biotech and industry face automation and energy grid challenges

Minerva Imaging, a biotechnology company based in Ølstykke, has implemented robotic automation to address growth-driven bottlenecks in its laboratory processes. The company, which assists global pharmaceutical firms in developing treatments for cancer and cardiovascular diseases, previously relied on manual methods for preparing and weighing tissue samples. By utilizing a robot capable of operating 24/7, the company aims to increase efficiency and reduce human exposure to radioactive materials. The transition was supported by the Teknologisk Institut through the EDOcobot EU project, which provided a testing environment for various robotic solutions.

Separately, Danish industrial leaders are warning of economic risks due to electricity grid limitations. Novonesis, a major biosolutions company, has indicated it may bypass Denmark for production expansions due to a lack of clear commitments regarding grid connections. Other companies, including FF Skagen and Stena Line, have reported difficulties transitioning from fossil fuels to electricity due to insufficient power availability. In response, Dansk Industri has proposed a shift toward more state-directed energy planning to ensure industrial electricity needs are met.